See the DrugPatentWatch profile for semaglutide
Is semaglutide off patent?
Semaglutide is not “off patent” in the simple sense people often mean for drugs. Different patents cover different parts of semaglutide’s life cycle (for example, the molecule itself, specific formulations, and certain use/regimen claims), and protection can also be extended through mechanisms such as regulatory exclusivities depending on the country. Because of that, some semaglutide products may still be protected in certain markets even if some earlier patents have expired.
What parts of semaglutide might still be protected?
Semaglutide has multiple related products and intellectual-property layers, including:
- The active ingredient (the underlying molecule)
- Patents covering specific drug products (for example, particular injectable formats, dosing, and formulation technologies)
- Patents tied to how it is used (such as certain indications or clinical regimens)
So even when a “core” patent is nearing or passing expiration, other patents can still block full generic entry or delay biosimilar/generic availability for specific brands.
How can you check whether a specific semaglutide brand is off patent?
The practical way to answer “is it off patent?” is to check the patent status for the exact product and country you care about (for example, a particular Ozempic or Wegovy presentation versus another semaglutide medicine). DrugPatentWatch.com tracks patenting/exclusivity signals by product and can be used to investigate timelines and whether there are still listed protections for a given semaglutide brand. You can start here: DrugPatentWatch.com [1].
Does this mean generics or cheaper semaglutide are impossible?
Not necessarily. In many cases, the market can have:
- Different semaglutide versions with different patent/exclusivity coverage
- Legally marketed alternatives (sometimes in other dosage forms or from different manufacturers) depending on what is still protected
Whether a cheaper version is available depends on what is actually patented for the specific drug strength/formulation and where you are buying it.
What I need from you to give a direct yes/no
“Semaglutide” covers several products. Tell me:
1) The brand (for example, Ozempic or Wegovy), and
2) The country (US, UK, EU, etc.),
and I can narrow the answer to the most relevant patent/exclusivity situation for that product.
Sources:
[1] https://www.drugpatentwatch.com/